Author Correction: Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway.

Mengrui Wu, Wei Chen, Yun Lu, Guochun Zhu, Liang Hao, Yi-Ping Li

Abstract readPublished Erratum

In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Rhusflavone Modulates Osteoclastogenesis Through RANKL-Induced AKT Signaling in Bone Marrow-Derived Macrophages.International journal of molecular sciences · 2025
Article
Mechanism of Huangqi Sanxian Decoction Inhibiting Osteoclast Differentiation Based on Network Pharmacology.Evidence-based complementary and alternative medicine : eCAM · 2022
Article
Isorhamnetin 3-O-neohesperidoside promotes the resorption of crown-covered bone during tooth eruption by osteoclastogenesis.Scientific reports · 2020
Article

4 · The record

Corrections and comments

Erratum for
Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway.2017

5 · Who and what money

Authors and funding

6 authors.

Mengrui WuDepartment of Pathology, University of Alabama at Birmingham, SHEL 810, 1825 University Boulevard, Birmingham, AL, 35294-2182, USA.

Wei ChenDepartment of Pathology, University of Alabama at Birmingham, SHEL 810, 1825 University Boulevard, Birmingham, AL, 35294-2182, USA. wechen@uab.edu.

Yun LuDepartment of Pathology, University of Alabama at Birmingham, SHEL 810, 1825 University Boulevard, Birmingham, AL, 35294-2182, USA.

Guochun ZhuDepartment of Pathology, University of Alabama at Birmingham, SHEL 810, 1825 University Boulevard, Birmingham, AL, 35294-2182, USA.

Liang HaoDepartment of Pathology, University of Alabama at Birmingham, SHEL 810, 1825 University Boulevard, Birmingham, AL, 35294-2182, USA.

Yi-Ping LiDepartment of Pathology, University of Alabama at Birmingham, SHEL 810, 1825 University Boulevard, Birmingham, AL, 35294-2182, USA. ypli@uab.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31767881

DOI10.1038/s41467-019-13015-6

PMCPMC6877575

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.